DonateRead the latest blogs from across our work within the secondary breast cancer community. From blogs on fundraising, research findings, information sharing, corporate achievements, community support and stories, celebrate with us as we work together to Make 2nds Count.
20th December 2023
Aromatase Inhibitors for Secondary Breast Cancer: Science and Stories
Aromatase inhibitors are a class of drugs that can be used to treat hormone receptor-positive (HR+) subtypes of breast cancer1. Aromatase inhibitors can be used in the treatment of early HR+ breast cancer, but here we will focus on aromatase inhibitors in treating secondary (metastatic, advanced) breast cancer.